Direct Rx recalls Duloxetine D/R
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity above the proposed interim limit.
- Products
-
- Duloxetine D/R
- Company
- Direct Rx
- Where it was sold
-
Nationwide
Nationwide
- Units affected
- 16 bottles
- About this recall
- Duloxetine D/R, 20 mg, 30 Caps, 30-count bottle, RX Only, Packaged & Distributed by: Direct Rx, Dist. By Breckenridge Pharm., Inc., Berlin, CT 06037, NDC 61919-422-30